A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
Public ClinicalTrials.gov record NCT02614287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients With Migraine
Study identification
- NCT ID
- NCT02614287
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Interventions
- Galcanezumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2015
- Primary completion
- May 11, 2017
- Completion
- Aug 13, 2018
- Last update posted
- Jun 16, 2020
2015 – 2018
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Sunrise Clinical Research | Hollywood | Florida | 33021 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Albuquerque Neurosciences | Albuquerque | New Mexico | 87109 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Wilmington Health Associates | Wilmington | North Carolina | 28401 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Clinpoint Trial, LLC | Waxahachie | Texas | 75165 | — |
| Ericksen Research and Development | Clinton | Utah | 84015 | — |
| Blue Ridge Research Center | Roanoke | Virginia | 24018 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02614287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02614287 live on ClinicalTrials.gov.